ARTICLE | Strategy
Oxford Genome: Proteomics to products
October 23, 2006 7:00 AM UTC
Oxford Genome Sciences Ltd. started out life by building its Oxford Genome Anatomy Project from the core of assets plucked from an M&A deal and turning it into a discovery platform that maps clinical information and proteomics data from a variety of sources to about 15,000 human genes. Now it is developing a two-part business model that combines discovery services with partnerships to develop products
Christian Rohlff, founder and CEO, was director of proteome research collaborations at Oxford GlycoSciences plc from 2001 until the company was acquired in 2003 by Celltech Group plc, now part of UCB Group (Euronext:UCB, Brussels, Belgium)...